Skip to main content
ArticleOPEN ACCESS

Development of TRPM8 antagonists to treat chronic pain and migraine

Pharmaceuticals
DOI: 10.3390/ph10020037
70Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Abstract

A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.

Author supplied keywords

Cite

CITATION STYLE

APA

Weyer, A. D., & Lehto, S. G. (2017, June 1). Development of TRPM8 antagonists to treat chronic pain and migraine. Pharmaceuticals. MDPI AG. https://doi.org/10.3390/ph10020037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free